glp-1 drugs and pancreatitis Enzyme Rise May Link GLP-1, Wonderful new analysis: GLP-1RAs are

Current research focuses on creating stronger and longer GLP-1RAs with improved effectiveness and safety

The rising prevalence of these chronic conditions has led to an increased demand for effective treatments, including GLP-1 analogues, to control diabetes and weight

This is likely associated with rapid weight loss rather than a direct medication effect, representing a condition called telogen effluvium

Origins and tissue-context-dependent fates of blood monocytes

doi: 10.2337/dc24-S009 [DOI] [PMC free article] [PubMed] [Google Scholar] 14

Early open-label studies with relatively small sample sizes using GLP-1R agonists such as liraglutide (122, 123) and dulaglutide (124) show promising effects in reducing binge episodes and weight in BED, but further research is needed to confirm their benefits across diverse populations